Sotera Health Co. (NASDAQ: SHC) reported Q4 EPS of $0.26, in-line with the analyst estimate of $0.26. Revenue for the quarter came in at $310 million versus the consensus estimate of $300.4 million.

GUIDANCE:

Sotera Health Co. sees Q1 2024 EPS of $0.65-$0.75, versus the consensus of $0.87.
Net revenues and Adjusted EBITDA growth in the range of 4.0% to 6.0%,
Interest Expense in the range of $170 million to $180 million,
Tax rate applicable to Adjusted Net Income(1) in the range of 31.5% to 34.5%,
A weighted-average fully diluted share count in the range of 283 million to 285 million shares,
Capital expenditures in the range of $205 million to $225 million

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.